ACAD
Price
$22.12
Change
-$0.09 (-0.41%)
Updated
Jun 27 closing price
Capitalization
3.7B
32 days until earnings call
EPRX
Price
$5.30
Change
+$0.68 (+14.72%)
Updated
Jun 27 closing price
Capitalization
192.14M
41 days until earnings call
Interact to see
Advertisement

ACAD vs EPRX

Header iconACAD vs EPRX Comparison
Open Charts ACAD vs EPRXBanner chart's image
ACADIA Pharmaceuticals
Price$22.12
Change-$0.09 (-0.41%)
Volume$3M
Capitalization3.7B
Eupraxia Pharmaceuticals
Price$5.30
Change+$0.68 (+14.72%)
Volume$28.44K
Capitalization192.14M
ACAD vs EPRX Comparison Chart in %
Loading...
ACAD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACAD vs. EPRX commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACAD is a Hold and EPRX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 28, 2025
Stock price -- (ACAD: $22.12 vs. EPRX: $5.30)
Brand notoriety: ACAD and EPRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACAD: 124% vs. EPRX: 180%
Market capitalization -- ACAD: $3.7B vs. EPRX: $192.14M
ACAD [@Biotechnology] is valued at $3.7B. EPRX’s [@Biotechnology] market capitalization is $192.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACAD’s FA Score shows that 1 FA rating(s) are green whileEPRX’s FA Score has 0 green FA rating(s).

  • ACAD’s FA Score: 1 green, 4 red.
  • EPRX’s FA Score: 0 green, 5 red.
According to our system of comparison, ACAD is a better buy in the long-term than EPRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACAD’s TA Score shows that 4 TA indicator(s) are bullish while EPRX’s TA Score has 4 bullish TA indicator(s).

  • ACAD’s TA Score: 4 bullish, 5 bearish.
  • EPRX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, EPRX is a better buy in the short-term than ACAD.

Price Growth

ACAD (@Biotechnology) experienced а -2.60% price change this week, while EPRX (@Biotechnology) price change was +22.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +31.37%, and the average quarterly price growth was +12.88%.

Reported Earning Dates

ACAD is expected to report earnings on Jul 30, 2025.

EPRX is expected to report earnings on Aug 08, 2025.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACAD($3.7B) has a higher market cap than EPRX($192M). EPRX YTD gains are higher at: 67.192 vs. ACAD (20.545). ACAD has higher annual earnings (EBITDA): 102M vs. EPRX (-25.89M). ACAD has more cash in the bank: 682M vs. EPRX (27.5M). EPRX has less debt than ACAD: EPRX (52.8K) vs ACAD (56M). ACAD has higher revenues than EPRX: ACAD (996M) vs EPRX (0).
ACADEPRXACAD / EPRX
Capitalization3.7B192M1,928%
EBITDA102M-25.89M-394%
Gain YTD20.54567.19231%
P/E Ratio16.21N/A-
Revenue996M0-
Total Cash682M27.5M2,480%
Total Debt56M52.8K106,061%
FUNDAMENTALS RATINGS
ACAD: Fundamental Ratings
ACAD
OUTLOOK RATING
1..100
55
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
26
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACADEPRX
RSI
ODDS (%)
Bearish Trend 1 day ago
70%
Bearish Trend 1 day ago
67%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
67%
Bearish Trend 1 day ago
57%
Momentum
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
74%
MACD
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
71%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
71%
Bullish Trend 1 day ago
41%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
75%
Bullish Trend 1 day ago
40%
Advances
ODDS (%)
Bullish Trend 11 days ago
73%
Bullish Trend 1 day ago
84%
Declines
ODDS (%)
Bearish Trend 1 day ago
71%
Bearish Trend 4 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
80%
Aroon
ODDS (%)
Bullish Trend 1 day ago
66%
Bullish Trend 1 day ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
ACAD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
APHIX34.650.21
+0.61%
Artisan International Institutional
DURAX14.07N/A
N/A
DWS ESG International Core Eq A
MGTCX9.30N/A
N/A
Transamerica Mid Cap Growth C
GASFX28.42N/A
N/A
Hennessy Gas Utility Investor
MAMEX20.72N/A
N/A
MoA Mid Cap Equity Index Fund

ACAD and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACAD has been loosely correlated with INZY. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ACAD jumps, then INZY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACAD
1D Price
Change %
ACAD100%
-0.41%
INZY - ACAD
50%
Loosely correlated
-0.25%
AURA - ACAD
44%
Loosely correlated
-0.16%
CRSP - ACAD
42%
Loosely correlated
+1.69%
PRME - ACAD
40%
Loosely correlated
-8.68%
STTK - ACAD
39%
Loosely correlated
-8.27%
More

EPRX and

Correlation & Price change

A.I.dvisor tells us that EPRX and ETNB have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EPRX and ETNB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EPRX
1D Price
Change %
EPRX100%
+14.72%
ETNB - EPRX
28%
Poorly correlated
-1.01%
ACAD - EPRX
28%
Poorly correlated
-0.41%
CCCC - EPRX
28%
Poorly correlated
-6.59%
IOVA - EPRX
26%
Poorly correlated
-4.49%
ALEC - EPRX
25%
Poorly correlated
-1.33%
More